iHealthcare Group publishes 2026 annual report

  • Ihealthcare published its annual report for the year ended Feb. 28, 2026, flagging stronger momentum in its ophthalmology-focused operations.
  • Revenue rose 17.13% as the group expanded its capital equipment fleet, lifting associated consumables demand.
  • Operating performance improved on tighter cost control, a larger product offering, favorable foreign-exchange outcomes, and broader customer diversification.
  • Total cash resources increased to ZAR 8.77 million despite lower cash generated from operations, reflecting higher working-capital investment.
  • No dividends were declared; management kept its near-term outlook cautious while positioning for market opportunities into Feb. 28, 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ihealthcare Group Ltd. published the original content used to generate this news brief on May 29, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.